Back

Medscape, LLC

  • Liver Cirrhosis
  • Non-alcoholic Fatty Liver Disease

Getting to Grips With Noninvasive Tests to Assess Liver Fibrosis and Patient Eligibility for Novel MASH Therapies

The goal of this activity is for learners to be better able to understand the role of noninvasive tests (NITs) for liver fibrosis to identify appropriate patients for novel therapies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 credits

MOC types

ABIM — Medical KnowledgeUp to 1.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.25 credits
  • MOC · Up to 1.25 points
  • Commercial Support
  • Released
    Dec 3, 2025
  • Last day to claim credit
    Dec 4, 2026 8 weeks left